Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial
O'Brien, Susan, Prof, Furman, Richard R, MD, Coutre, Steven E, Prof, Sharman, Jeff P, MD, Burger, Jan A, MD, Blum, Kristie A, MD, Grant, Barbara, MD, Richards, Donald A, MD, Coleman, Morton, Prof, Wierda, William G, MD, Jones, Jeffrey A, MD, Zhao, Weiqiang, MD, Heerema, Nyla A, Prof, Johnson, Amy J, PhD, Izumi, Raquel, PhD, Hamdy, Ahmed, MD, Chang, Betty Y, PhD, Graef, Thorsten, MD, Clow, Fong, ScD, Buggy, Joseph J, PhD, James, Danelle F, MD, Byrd, John C, Prof
Published in The lancet oncology (01.01.2014)
Published in The lancet oncology (01.01.2014)
Get full text
Journal Article
Long-Term Efficacy and Safety of Single-Agent Ibrutinib at 3 Years Follow-up in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL)
O’Brien, Susan M., MD, Jones, Jeffrey A., MD, MPH, Furman, Richard R., MD, Coutre, Steven E., MD, Flinn, Ian W., MD, PhD, Burger, Jan A., MD, PhD, Blum, Kristie A., MD, Sharman, Jeff P., MD, Wierda, William G., MD, PhD, Zhao, Weiqiang, MD, PhD, Heerema, Nyla A., PhD, Johnson, Amy J., PhD, Tran, Anh, BS, Zhou, Cathy, Bilotti, Elizabeth, MSN, James, Danelle F., MD, MAS, Byrd, John C., MD
Published in Clinical lymphoma, myeloma and leukemia (01.06.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.06.2015)
Get full text
Journal Article
Gene therapy and active immune therapy of hematologic malignancies
Wierda, William G., MD, PhD, Kipps, Thomas J., MD, PhD
Published in Best practice & research. Clinical haematology (01.09.2007)
Published in Best practice & research. Clinical haematology (01.09.2007)
Get full text
Journal Article